Phase 2 N=10 The Effects of Sedatives on Tobacco Use Disorder
Tobacco Use Disorder
Primary: Side Effects — 1.3; 1.4 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=163 CAP-Ketamine for Antidepressant Resistant PTSD
PTSD · Posttraumatic Stress Disorder
Primary: PTSD Checklist (PCL) — 48.56; 46.62; 47.88 units on a scale
Phase 4 N=220 Losartan Effects on Emphysema Progression
Emphysema
Primary: Change in Mean pct950 — 1.35; 0.66 percentage of voxels — p=0.133
N/A N=45 BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment
Point-of-Care Bladder Ultrasound · Urethral Catheter
Primary: Time to Successful Completion of Pelvic Ultrasound — 103.95; 92.82 minutes
Phase 2 N=60 Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention
Fibrosis · Skin Scarring · Skin Wound
Primary: Change in Scar Pliability Between the Treated and Control Incision Sites as Measured by Skin Elasticity at 6 Months Compared to Baseline
Phase 2 N=46 Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
CoronaVirus Induced Disease-2019 (COVID-19)
Primary: Percentage of Participants Alive and Without Respiratory Failure Through Day 28 — 86.4; 79.2 percentage of participants — p==0.599
N/A N=125 Evaluation of the Rotational Stability of the Tecnis Toric II IOL
Cataract · Corneal Astigmatism
Primary: Percentage of Eyes With ≤ 5º Lens Axis Misalignment From the Intended IOL Axis of Orientation at the 1-week Postoperative Visit — 99.5 Percentage of Eyes
Phase 3 N=65 Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma
Severe Asthma
Primary: Number of Subjects With Adverse Events — 39 Participants
N/A N=9 Residential Cleaning of Indoor Air to Protect COPD Patients
Chronic Obstructive Pulmonary Disease
Primary: Mean Change in St. George Respiratory Questionnaire — -12.5; -0.45 score on a scale
Phase 2 N=124 Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection
Staphylococcal Infections · Surgical Site Infection
Primary: Change in S. Aureus Log CFU/mL From Baseline to Pre-surgery — -2.842; -0.469 log10 (CFU/mL)
Phase 2 N=39 A Study of Durvalumab (MEDI4736) in Esophageal Cancer
Esophageal Cancer
Primary: Percentage of Participants With One-Year Relapse Free Survival (RFS) With Post-Operative Durvalumab — 73 percentage of subjects
Phase 4 N=141 DPE Technique in Labor Epidural for Morbidly Obese Women
Morbid Obesity · Labor Pain
Primary: Number of Participants Who Required Asymmetric Block, Top-up Interventions, Catheter Adjustments, Replacement of Epidural Catheter, or Failure of Block Requiring…
N/A N=22 MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers
Stillbirth · Grief · Infant Death
Primary: Percentage of Participants Approached for Enrollment Who Signed up for the Study — 22 Participants
Phase 2 N=165 Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib
Primary Myelofibrosis · Post-Polycythemia Vera Myelofibrosis · Post- Essential Thrombocythemia Myelofibrosis
Primary: Spleen Volume Reduction Response (≥ 35%) — 0; 2; 2; 0 Participants
Phase 4 N=68 Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine.
Chronic Migraine, Headache
Primary: Verbal Pain Scale — 5.3; 3.3 score on a scale